Cargando…
Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors
Recent studies have shown that the brain is not a barrier to successful active immunotherapy that uses gene-modified autologous tumor cell vaccines. In this study, we compared the efficacy of two types of vaccines for the treatment of tumors within the central nervous system (CNS): dendritic cell (D...
Autores principales: | Ashley, David M., Faiola, Brenda, Nair, Smita, Hale, Laura P., Bigner, Darell D., Gilboa, Eli |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199074/ https://www.ncbi.nlm.nih.gov/pubmed/9314567 |
Ejemplares similares
-
A novel bispecific antibody recruits T cells to eradicate tumors in the “immunologically privileged” central nervous system
por: Choi, Bryan D., et al.
Publicado: (2013) -
Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity
por: Mosaheb, Mubeen M., et al.
Publicado: (2020) -
Oncolytic poliovirus directs tumor antigen presentation and T cell activation in vitro
por: Brown, Michael C, et al.
Publicado: (2015) -
Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling
por: Brown, Michael C., et al.
Publicado: (2021) -
Critical Points of Tumor Necrosis Factor Action in Central Nervous System Autoimmune Inflammation Defined by Gene Targeting
por: Körner, Heinrich, et al.
Publicado: (1997)